Investment Management of Virginia’s CollPlant Biotechnologies CLGN Stock Holding History

Investment Management of Virginia’s Portfolio CLGN Stock Details CLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$3.26M	Hold	463,899	–	–	0.62%	53
2022 Q4	$3.87M	Buy	463,899 +60,326	+15%	+$413K	0.76%	45
2022 Q3	$2.74M	Buy	403,573 +57,040	+16%	+$463K	0.59%	61
2022 Q2	$2.77M	Sell	346,533 -97,911	-22%	-$899K	0.57%	62
2022 Q1	$4.99M	Sell	444,444 -171,110	-28%	-$1.88M	0.88%	33
2021 Q4	$10.1M	Buy	615,554 +44,653	+8%	+$797K	1.62%	17
2021 Q3	$9.65M	Buy	570,901 +40,797	+8%	+$733K	1.85%	12
2021 Q2	$11.2M	Sell	530,104 -296	-0.1%	-$4.73K	2.16%	6
2021 Q1	$7.13M	Buy	530,400 +245,268	+86%	+$3.7M	1.44%	17
2020 Q4	$3.07M	Buy	285,132 +10,016	+4%	+$80.9K	0.67%	54
2020 Q3	$2.29M	Buy	275,116 +100,000	+57%	+$900K	0.57%	60
2020 Q2	$1.75M	Buy	175,116 +17,000	+11%	+$175K	0.44%	68
2020 Q1	$1.46M	Buy	+158,116	New	+$1.62M	0.44%	75

Other funds holding CLGN

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BFEC

Benjamin F. Edwards & Company St. Louis, Missouri $5.69B AUM 15.37% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

SQA

Simon Quick Advisors Morristown, New Jersey $2.48B AUM 21.26% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Investment Management of Virginia's CLGN Position: Q1 2023 in Review

Investment Management of Virginia held its CollPlant Biotechnologies (CLGN) position steady in Q1 2023 at 463,899 shares worth $3.26M. The position accounts for 0.62% of the portfolio, ranked #53.

Investment Management of Virginia first reported a position in CLGN in Q1 2020 and has held it in 13 quarters since. The position peaked at $11.2M in Q2 2021. 18 funds tracked by Wall St. Rank hold CLGN as of Q1 2023.

Investment Management of Virginia held 463,899 shares of CollPlant Biotechnologies worth $3.26M as of Q1 2023.
Investment Management of Virginia left its CollPlant Biotechnologies share count unchanged in Q1 2023.
CollPlant Biotechnologies made up 0.62% of Investment Management of Virginia's portfolio in Q1 2023, its #53 holding.
Investment Management of Virginia first reported a position in CollPlant Biotechnologies in Q1 2020 and has held it in 13 quarters since.
Investment Management of Virginia's CollPlant Biotechnologies position peaked at $11.2M in Q2 2021.
18 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q1 2023.

Based on Investment Management of Virginia's 13F filing for Q1 2023, filed 26 Apr 2023.